Inactive

The Force Health Protection division of the US Army Medical Materiel Development Activity is determining whether a commercial solution can be provided to meet cGMP requirements for contract transition... The Force Health Protection division of the US Army Medical Materiel Development Activity is determining whether a commercial solution can be provided to meet cGMP requirements for contract transition, accountability, storage, distribution, disposal, maintenance, security, handling, packing, shipping, and transportation of Government owned biological-related materials that may be intended for human use (cGMP). Such biological materiel may include, but is not limited to, vaccines, drugs, other biologics, laboratory samples or clinical samples. See attachments for details. Amendment 1 (26 June 2020) - The purpose of this amendment is to extend the due date for responses to 10 July 2020.